Journal: Journal of Nanobiotechnology
Article Title: Microglia-specific interleukin-4 delivery by engineered extracellular vesicles restores inner blood-retinal barrier in diabetic retinopathy via GAS6-MERTK pathway
doi: 10.1186/s12951-025-03976-w
Figure Lengend Snippet: IL4@EV regulated endothelial cell and pericyte function. A Schematic showing experimental design and sample groups for an analysis of the function of HRMECs and pericytes. Microglia were stimulated with 1 µg/mL LPS to induce M1 type before exposed to PBS, free IL4, unmodified EV, or IL4@EV for 24 h. M1 microglia were presented in an ameboid larger manner and M2 or resting microglia were in smaller size with branches. B-C Transwell assays were performed to assess HRMECs migration ability ( n = 3). Scale bar: 100 μm. D-E Scratch wound healing assay were performed to assess HRMECs migration ability ( n = 3). Scale bar: 100 μm. F-G Flow cytometry analysis of the cell-death-inducing effect of microglia on pericytes by using annexin V/PE apoptosis detection ( n = 3). Percentages indicated the proportion of early and late apoptotic cells. H Blood–retinal barrier integrity was assessed by FITC‑dextran in co‑cultures of HRMECs with pericytes ( n = 3). * P < 0.1, ** P < 0.01, *** P < 0.001, **** P < 0.0001
Article Snippet: To detect M1 polarization of primary microglia in vitro, the cells were treated with LPS (1 μg/mL) for 24 h and then subjected to incubate with CD86-allophycocyanin (APC) (1:50; APC-65068, Proteintech) for 45 min at room temperature.
Techniques: Migration, Wound Healing Assay, Flow Cytometry